Abstract:OBJECTIVE:To study the distribution of IL-6 receptors (CD(126) and CD(w130)) on lymphocytes in patients with lupus nephritis (LN). METHOD:The percentages of lymphocyte subsets were examined by direct two colour immunofluorescence on flow cytometry. RESULTS:(1) In active and inactive cases, the percentages of CD(+)(4) cells obviously decreased as compared with the normal controls (P < 0.01). Increased numbers of CD(+)(8) cells could be detected in LN patients (P < 0.05), especially in active cases (P < 0.01). Lymphocytes of active cases contained significantly greater percentage of CD(+)(23) cells than those of normal subjects (P < 0.05). On the contrary, the percentage of CD(+)(23) cells was statistically lower in the inactive cases than in normal subjects (P < 0.01). No significant difference in the percentages of CD(+)(126) and CD(+)(w130) cells was observed among the active, inactive and healthy groups (P > 0.05); (2) The proportion of CD(+)(4) CD(+)(126) and CD(+)(4) CD(+)(w130) cells in total lymphocytes was significantly lower in the active than in the inactive ones or normal subjects (P < 0.05; P < 0.01), whereas that of CD(+)(8) CD(+)(126) and CD(+)(8) CD(+)(w130) cells was not different among the active, inactive and normal subjects (P > 0.05). The proportion of CD(+)(23) CD(+)(126) cells and CD(+)(23) CD(+)(w130) cells augmented significantly in the active (P < 0.05), whereas it lessened in the inactive without statistical meaning as compared with the normal subjects (P > 0.05). (3) There was a positive correlation between the percentage of CD(+)(23) CD(+)(126) cells and that of CD(+)(23) CD(+)(w130) cells in total lymphocytes in the active group (r = 0.756, P < 0.05). However, no correlation between the percentage of CD(+)(23) CD(+)(126) cells and that of CD(+)(23) CD(+)(w130) cells in total lymphocytes was found in the inactive (r = 0.376, P > 0.05) or normal group (r = 0.256, P > 0.05); (4) The fraction of CD(+)(23) cells expressing CD(126) and CD(w130) was related to the SLE disease activity index (SLEDAI) and lymphopenia (P < 0.05, P < 0.005). But it was neither associated with the number of damaged organs and the degree of damage, not with that of ANA, anti-dsDNA antibody and complements (C(3) and C(4)) (P > 0.05). CONCLUSIONS:LN patients present not only B cell hyperactivity but also T cell abnormality. In active cases, there is abnormal distribution of IL-6 receptors on lymphocytes: reduced CD(126) and CD(w130) expression on CD(+)(4) cells and elevated CD(126) and CD(w130) expression on CD(+)(23) cells. Detecting the proportion of CD(+)(23) CD(+)(126) cells or CD(+)(23) CD(+)(w130) cells in total lymphocytes may serve as one of activity indexes for LN patients.

The expression of IL-18 and IL-18BP in lupus nephritis patients and ameliorating effects of immunosuppressors

Expressions of IL-18 and Its Binding Protein in Peripheral Blood Leukocytes and Kidney Tissues of Lupus Nephritis Patients

Increased Urinary Interleukin 22 Binding Protein Levels Correlate with Lupus Nephritis Activity

Early-stage predictors for treatment responses in patients with active lupus nephritis.

Elevated Interleukin-18 and Skewed Th1:Th2 Immune Response in Lupus Nephritis

Levels of serum IL-18 and IL-34 in patients with lupus nephritis and their significance

Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus

IGFBP2 Function As a Novel Biomarker for Active Lupus Nephritis.

Quantitative Expression of Interleukin-23 and Interleukin-12 Subunits in Systemic Lupus Erythematosus Patients

Identification and Validation of IFI44 As Key Biomarker in Lupus Nephritis.

Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice

Increased Interleukin-22 Levels in Lupus Nephritis and Its Associated with Disease Severity: a Study in Both Patients and Lupus-Like Mice Model.

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: from a Southern Chinese Han Population

Study on Expression of Interleukin-10 Mrna,interleukin-18M RNA and Fas Mrna in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

Analysis of Interleukin 19 Serum Levels and Single Nucleotide Polymorphisms in Systemic Lupus Erythematosus.

Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients

[Distribution of Interleukin-6 Receptors (CD(126) and CD(w130)) on Circulating Lymphocytes in Patients with Lupus Nephritis].

Change and Significance of Interleukin-18 in Patients with Systemic Lupus Erythematosus

[Abnormality and Significance of Interleukin-9 and CD4(+)interleukin-9(+) T-cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus].

Effect and significance of urine protein from patients with lupus nephritis to the expression of NF-κB,TNF-α and IL-6